AbbVie (ABBV), Pfizer (PFE), Merck (MRK), Bristol-Myers Squibb (BMY), Johnson & Johnson (JNJ) and Eli Lilly (LLY) sport nice yields, concerns about slow growth notwithstanding, Lawrence Strauss writes in this week’s edition of Barron’s: https://bit.ly/2kZngPt
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.